NDC 73535-208

MONJUVI

Tafasitamab-cxix

MONJUVI is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Morphosys Us Inc.. The primary component is Tafasitamab.

• Product ID: 73535-208_1b090934-c99f-4232-9a57-9467e86e5134
• NDC: 73535-208
• Product Type: Human Prescription Drug
• Proprietary Name: MONJUVI
• Generic Name: Tafasitamab-cxix
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2020-08-05
• Marketing Category: BLA / BLA
• Application Number: BLA761163
• Labeler Name: MorphoSys US Inc.
• Substance Name: TAFASITAMAB
• Active Ingredient Strength: 200 mg/5mL
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 73535-208-01

1 VIAL in 1 CARTON (73535-208-01) > 5 mL in 1 VIAL

• Marketing Start Date: 2020-08-05
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details